Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole pharmacokinetics for antifungal prophylaxis in hematology patients
NL-OMON43127Phase 4Active, not recruiting
- Sponsor
- Ziekenhuisapotheek
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of posaconazole in invasive mycoses (2 arms), sponsored by Ziekenhuisapotheek. Primary endpoints: Population pharmacokinetics of posaconazole, Impact of mucositis on absorption or presystemic clearance and 1 more. Started Jan 2017; status: active, not recruiting.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on NL-OMON43127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43127.